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SUMMARY
Objective: Seizure disorder is one of themost relevant clinical manifestations inWolf-
Hirschhorn syndrome (WHS) and it acts as independent prognostic factor for the
severity of intellectual disability (ID). LETM1, encoding amitochondrial protein playing
a role in K+/H+ exchange and in Ca2+ homeostasis, is currently considered the major
candidate gene. However, whether haploinsufficiency limited to LETM1 is enough to
cause epilepsy is still unclear. Themain purpose of the present research is to define the
4p chromosome regions where genes for seizures reside.
Methods: Comparison of our three unusual 4p16.3 deletions with 13 literature reports.
Array-comparative genomic hybridization (a-CGH). Real-time polymerase chain reac-
tion (RT-PCR) onmessanger RNA (mRNA) of LETM1 and CPLX1. Direct sequencing of
LETM1.
Results: Three unusual 4p16.3 deletions were detected by array-CGH in absence of a
obvious clinical diagnosis of WHS. Two of these, encompassing LETM1, were found in
subjects who never had seizures. The deletions were interstitial, spanning 1.1 Mb with
preservation of the terminal 1.77 Mb region in one case and 0.84 Mbwith preservation
of the terminal 1.07 Mb region in the other. The other deletion was terminal, affecting
a 0.564 Mb segment, with preservation of LETM1, and it was associated with seizures
and learning difficulties. Upon evaluating our patients along with literature reports, we
noted that six of eight subjects with terminal 4p deletions preserving LETM1 had sei-
zures, whereas seven of seven with interstitial deletions including LETM1 and preserv-
ing the terminal 1 Mb region on 4p did not. An additional chromosome region for
seizures is suggested, falling within the terminal 1.5 Mb on 4p, not including LETM1.
Significance: We consider that haploinsufficiency not limited to LETM1 but including
other genes acts as a risk factor for theWHS-associated seizure disorder, according to
a comorbidity model of pathogenesis. Additional candidate genes reside in the termi-
nal 1.5 Mb region on 4p,most likely distal to LETM1.
KEYWORDS: WHS pathogenesis, Candidate genes, Seizures.
Dr. Marcella Zollino is
Associate Professor in
Medical Genetics at the
Institute of Medical
Genetics at Catholic
University in Rome.
Daniela Orteschi is a
biologistat theInstitute
of Medical Genetics at
Catholic University in
Rome.
849
FULL-LENGTHORIGINALRESEARCH
Wolf-Hirschhorn syndrome (WHS, OMIM 194190)
(OMIM: Online Mendelian Inheritance in Man, http://
omim.org/) is a contiguous gene deletion disorder caused
by partial deletion of the short arm of one chromosome 4.
Several literature reports point to a great variability of the
WHS phenotype, depending mostly on the variability of
the underlying genomic defect.1–3 However, there is a con-
sensus in considering the core phenotype as defined by the
association of severe growth delay, including both short
stature and low body weight with thin habitus, intellectual
disability (ID), distinctive facial appearance (featuring the
well-known Greek warrior helmet profile), and seizures (or
electroencephalography [EEG] anomalies). All these signs
map within the terminal 1.9 Mb region on 4p16.3, where
the critical region, Wolf-Hirschhorn Syndrome Candidate
Region 2 (WHSCR-2), was described.4 Typical WHS is a
contiguous gene deletion disorder, since haploinsufficiency
of many genes among those included in the critically
deleted region was inferred to cause the core phenotype.2,3
WHSC1 is an excellent candidate gene for both facial char-
acteristics and growth delay. LETM1 is currently consid-
ered the major gene for seizures. It encodes a protein for
the inner mitochondrial membrane, playing a role in mito-
chondrial K+/H+ (KHE) and Ca2+/H+ exchange, in main-
taining the mitochondrial membrane potential, and in the
export of proteins involved in the assembly of respiratory
complexes.5–8 Supporting this pathogenic link, mitochon-
dria are currently considered to play an important role in
the pathogenesis of seizures.9 However, the unique role of
LETM1 in causing epilepsy appears to be question-
able.2,10,11
We report on three unusual deletions on 4p16.3 that are
not productive of a full WHS phenotype. WHSCR-2
(LETM1 included) was haploinsufficient in two subjects
who never had seizures, whereas it was preserved, with
preservation of LETM1 as well, in two siblings, in their
father, and in their paternal grandmother, who all had sei-
zures. Our observations, supported by literature data,
allowed us to suggest a comorbidity model of pathogenesis
for the WHS-associated seizure disorder, and to define an
additional chromosome region where new candidate genes
likely reside. To allow proper genetic diagnosis and a geno-
mic-based antiepileptic surveillance, WHS is also discussed
at a nosologic level. This latter point is presented as a useful
tool for transferring into clinical practice the fine molecular
data provided by the currently available techniques for deep
genotyping.
Methods
Subjects
Subject 1
This is a 9-year-old Dutch boy who was born at term by
cesarean section because of fetal distress after uneventful
pregnancy. Birth weight was 2,940 g (5th percentile).
Length and head circumference were not referred. Poor
sucking and slight hypotonia were observed at birth. He sat
unsupported at 12 months and walked independently at
19 months. Language was delayed, still limited to single
words and short sentences that were ill-articulated. A mod-
erate degree of ID of about 50 was diagnosed by formal IQ
evaluation. Attention deficit/hyperactivity disorder
(ADHD) was diagnosed at age 6 years, and the patient was
in special education. He never had seizures and his EEG
was normal. The boy was not yet toilet-trained and his
motor development lag behind with stiff movements and
frequent falls. He had outbursts of laughter and a tendency
to overeat.
On physical examination, he appeared as a restless boy
with little contact with the observer, nonfluent movements
of hands, and hand-flapping. At age 6 years and 2 months,
his height was 116 cm (20th percentile) and occipitofrontal
circumference 48 cm (<2nd percentile). Facial characteris-
tics were only partially consistent with WHS, including up-
slanting palpebral fissures, slightly protruding eyes, mild
ptosis, arched eyebrows, high nasal bridge, and slightly
dysplastic and protruding ears. Flat mid-face and microret-
rognathia were also noted (Fig. 1). The extremities showed
joint hyperlaxity, long fingers with clinodactylous fifth
fingers, flat feet with clinodactyly of toes 4 and 5, as well
as a broad hallux and short distal phalanges, bilaterally.
Major malformations were not detected. At last examina-
tion, at age 9 years, seizures are still absent and EEG is
normal.
Subject 2
A 4-year-old boy, born at term with birth weight of
2,600 g (3rd percentile), length 46 cm (3rd percentile),
and head circumference 32 cm (2nd percentile), was
referred to us because of hypotonia and mild ID. He sat
unsupported at 8 months and walked independently at
24 months. Language was delayed, limited to about
20 words, but comprehension was good, and interaction
with the environment was excellent. He never had sei-
zures, and EEG was repeatedly normal. At age 3 years,
weight was 10 kg (3.5 standard deviation [SD]), height
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Figure 1.
Chromosome mapping of selected 4p deletions, including present cases, with respect to Wolf-Hirschhorn syndrome critical region-2
(WHSCR-2). Clinical pictures of subject 4 and her father and of subjects 2 and 1 are shown on the top. Dark bar on the bottom shows the
here-suggested chromosome region for the full WHS phenotype. Gray-shaded area highlights the deletions involving LETM1. The associ-
ated clinical signs are summarized in Table 1.
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was 81 cm (4.5 SD), and head circumference was
45.6 cm (4 SD). He presented with facial characteris-
tics partially mimicking the WHS features, including
triangular face, frontal bossing, large eyes, beaked nose
with high nasal bridge, downturned mouth, and large ears
(Fig. 1). He had clinodactylous third and fourth toes on
the right. His behavior was friendly and eye contact was
excellent. Brain magnetic resonance imaging (MRI) and
results of cardiac and kidney ultrasound examination
were normal. At age 4 years EEG was normal, and the
patient never experienced seizures.
Subjects 3 and 4
Subjects 3 and 4 are brother (3) and sister (4), aged 14
and 6 years, respectively, who were referred because of
seizures and learning difficulties. Height, weight, and
head circumference measurements had all been around the
50th centile since birth. They had no hypotonia. Facial
characteristics were unremarkable (Fig. 1; photos of sub-
ject 3 are not available). Motor development was normal
in the boy, whereas it was slightly delayed in the girl. The
epileptic disorder consisted, in the boy, of complex febrile
seizures in the first year of life and generalized febrile sei-
zures at age 8 years. EEG examination showed a normal
background activity and slow-waves with superimposed
spike discharges on anterior cortical regions during wake
and sleep. The girl had daily atypical absence seizures
with oral automatisms and eyelid myoclonus since 6 years
of age. The interictal EEG was characterized by normal
background activity and rhythmic 3 Hz slow-waves with
superimposed spikes discharges on anterior and posterior
regions. The ictal EEG was characterized by irregular,
generalized at 2.5–3 Hz spike-wave discharge with asyn-
chronous onset, clinically associated with loss of contact
and eyelid myoclonus or oral automatism. Both children
underwent molecular testing for mutation in SCN1A gene,
with normal results. Of note, the father had febrile sei-
zures and learning difficulties as a child, although he is
currently healthy and a skilled worker. He underwent phe-
notypic evaluation once he was diagnosed to carry the
same 4p deletion of his children. Large eyes, arched eye-
brows, and high nasal bridge were noted. The paternal
grandmother of subjects 3 and 4 underwent the first clini-
cal survey at the age of 63 years, at our suggestion. Bio-
metric parameters were normal. Facial characteristics
were on average unremarkable, and limited to high nasal
bridge, large and protruding eyes, and down-slanting pal-
pebral fissures. Although specific tests were not carried
out, her intellectual performance appeared to be within
lower limits. She attended a public school until the age of
11 years. Moreover, she can read and write, and was able
to take care of her family. She had a single prolonged
generalized tonic–clonic seizure episode with fever at age
2 years. She denied permission to publish clinical pic-
tures.
Genetics
Genetic investigations included array–comparative geno-
mic hybridization (array-CGH), locus-specific fluorescence
in situ hybridization (FISH) analysis, real-time polymerase
chain reaction (real time-PCR) on messenger RNA
(mRNA), and direct gene sequencing.
Array-CGH
Array-CGH was performed on genomic DNA from
uncultured peripheral blood cells at an average resolution of
35 kb (244K kit; Agilent Technologies, Santa Clara, CA,
U.S.A.), following the manufacturer’s instructions. Probe
alignments were referred to NCBI 37 (NCBI: National Cen-
ter for Biotechnology Information, http://www.ncbi.nlm.
nih.gov/), UCSC (UCSC: University of California, Santa
Cruz, http://genome.ucsc.edu/) hg19 build.
Locus-specific FISH experiments
FISH were carried out on metaphase chromosomes
according to standardized procedures on both parents in
each occasion, with the purpose to look for the presence of
4p deletion as in their child or for balanced chromosome
rearrangements. Molecular probes were selected on the
basis of individual extent of the 4p deletion.
Real-time PCR
Real-time PCR was performed to measure levels of
LETM1 and CPLX1mRNA extracted from peripheral blood
cells by TaqMan Gene Expression Assay (Hs00360061_m1
LETM1, Hs00362510_m1 CPLX1 from Life Technologies,
Carlsbad, CA, U.S.A.). Experimental data were obtained
with the SDS v.2.2.2 Software (Applied Biosystems Carls-
bad, CA, U.S.A.) and the comparative threshold cycle (Ct)
method (with the calculation of the 2DDCT) was used for
subsequent analysis, comparing LETM1 and CPLX1 versus
glyceraldehyde-3-phosphate dehydrogenase (GAPDH,
Hs99999905_m1; Applied Biosystems). Real-time PCR
reactions of each sample were performed in triplicate, and
experiments were repeated three times.
Direct gene sequencing
Sanger sequencing of coding regions of LETM1 (exons
and intron–exon boundaries) was performed on samples
from subjects 3 and 4, their father, and their paternal grand-
mother. Primer sequences are available on request.
Results
Array-CGH and FISH
Subject 1
An interstitial deletion spanning about 1.1 Mb on chro-
mosome region 4p16.3 was detected by array-CGH, with
breakpoints at 1.77 Mb from the 4p telomere, distally,
and at 2.90 Mb from the 4p telomere, proximally,
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defining the following karyotype: arr 4p16.3(1,778,765–
2,909,499)x1. Included in the deletion interval were
WHSC1 and LETM1 and additional 17 transcribed genes
(FGFR3, WHSC2, SCARNA22, C4orf48, NAT8L, POLN,
HAUS3, MXD4, ZFYVE28, RNF4, FAM193A, TNIP2,
SH3BP2, ADD1, MFSD10, NOP14, and C4orf10). Both
parents were analyzed with use of FISH with the WHSC1-
specific 190b4 cosmid probe, and with a 4p subtelomeric
probe (VYSIS, ToTel Vision; Abbott Laboratories, Abbott
Park, IL, U.S.A.), with normal results. Accordingly, a de
novo occurrence of the deletion was established in the
child.
Subject 2
The 4p16.3 deletion detected by array-CGH spanned
about 0.840 Mb, with breakpoints at 1.07 Mb from the 4p
telomere distally, and at 1.91 Mb from the 4p telomere
proximally. The deletion encompassed WHSC1, LETM1,
and additional 15 transcribed genes (RNF212, TMED11P,
SPON2, CTBP1, MAEA, KIAA1530, UVSSA, CRIPAK,
FLJ34443, DNTNP, FAM53A, SLBP, TMEM129, TACC3,
and FGFR3). The karyotype was defined as: arr 4p16.3
(1,079,721–1,919,855)x1. The rearrangement was assessed
to be de novo, with both parents having normal results on
FISH analysis with the WHSC1-specific 190b4 cosmid
probe.
Subjects 3 and 4
These siblings were found to carry a 0.564 Mb terminal
deletion on 4p16.3, preserving both the candidate genes
WHSC1 and LETM1, with karyotype defined as arr 4p16.3
(71,552–564,593)x1. The deletion included eight tran-
scribed genes (ZNF718, ZNF595, ZNF876P, ZNF732,
ZNF141, ABCA11P, ZNF721, and PIGG). The 4p subtelo-
meric FISH probe was found to be deleted in both the father
and the paternal grandmother. With use of array-CGH, the
father’s 4p deletion appeared to be identical to that of his
children and mother.
Results and partial gene content of individual deletions
are shown in Figure 1.
Real-time PCR
Semiquantitative real-time PCR on LETM1 mRNAs was
performed on patient 2 (LETM1 deleted), and on patient 4
and her father (LETM1 preserved). As expected, LETM1
expression was significantly reduced in patient 2, whereas
in patient 4 and in her father no diminished dose of LETM1
mRNA was noted in comparison to controls. Therefore,
transcription impairment of LETM1 due to positional effects
was ruled out in patients who had LETM1 preserved. The
limited level of expression of CPLX1 in peripheral blood
cells hampered the correct assessment of mRNA level both
in patients and in control subjects; however, a slightly
decreased expression was observed in patient 4 and in her
father, who both had CPLX1 preserved (Fig. 2).
Sanger sequencing
No variants of the coding sequence of LETM1 were
detected, apart from one single nucleotide polymorphism
(SNP; rs116753949), which shows a minor allele frequency
of 5% in a control population of European ancestry (1,000
genomes data: http://www.1000genomes.org).
Discussion
We discuss genotype–phenotype correlations in two
patients and a family with unusual 4p16.3 deletions that
were detected during the application of molecular karyotyp-
ing to the diagnosis of ID in the absence of obvious clinical
evidence of WHS. The main purpose of this report is an
attempt to elucidate the pathogenic mechanism underlying
epilepsy inWHS.
A B
Figure 2.
Graphs of semiquantitative real-time PCR results on subjects 2 and 4, and on the father of subjects 3 and 4. Data represent average fold
changes (2DDCT)  SD. (A) LETM1 mRNA levels. (B) CPLX1 mRNA levels. The high standard deviation (and the resulting low signifi-
cance of the results) is likely due to the low expression levels of the CPLX1 transcript in peripheral blood (i.e., threshold cycles were
around 35).
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WHS is a contiguous gene syndrome characterized by
great variability of the basic genomic defect.2–4,12 Although
the associated clinical phenotype varies greatly in individ-
ual patients, depending mainly on the size of the 4p deletion,
there is a consensus in considering the core WHS phenotype
as defined by the association of severe growth delay, ID,
typical facial appearance featuring the well-known Greek
warrior helmet profile, and seizures (or EEG anomalies).2,3
All these signs were mapped within the terminal 1.9 Mb
region on 4p16.3, where the critical region, WHSCR-2, was
described.4 Of importance, seizures represent one of the
greatest problems in the clinical management of WHS and
they act as an independent prognostic factor for the final
degree of ID. Characterizing the pathogenic genes for sei-
zures could allow a better elucidation of disease mecha-
nisms that in turn should facilitate development of targeted
therapy.
Wide evidence exists that the core WHS phenotype is
caused by haploinsufficiency of many genes.2,3 Among
those included in the critically deleted region,WHSC1 is the
major candidate gene for growth delay and facial dysmor-
phisms and LETM1 the major gene for seizures. LETM1,
deleted in nearly the totality of WHS patients with full clini-
cal presentation, encodes a mitochondrial protein with two
putative Ca2+ binding EF hands, which is involved in mito-
chondrial K+/H+ (KHE)6 and Ca2+/H+ exchange,8 in main-
taining the mitochondrial membrane potential and in the
export of proteins of the respiratory complexes.5–8 The
likely pathogenic role of LETM1 in causing seizures has
been supported by the evidence that mitochondria play a rel-
evant role in the pathogenesis of epilepsy.9 However, there
is no proven direct-link between haploinsufficiency of
LETM1, mitochondrial dysfunction, and epilepsy in
humans. On the other hand, it was observed that knockout
of Letm1 in mice results in early embryonic lethality in
homozygous carriers, whereas half of the heterozygotes sur-
vive, showing increased susceptibility to seizures after kai-
nic acid application, with a seizure score about 1.5-fold
higher than in wild-type mice.13 Moreover, high frequency
and prolonged duration of seizures was noted after Letm1
knock-down in rats exposed to pilocarpine. by intrahippo-
campal injection of a lentivirus bearing LV-Letm1-sh.14
Although no spontaneous seizures were noted, these data
suggest that Letm1 can play a role in predisposing to
epilepsy.
Two of the 4p16.3 unusual deletions we report here
encompassed a 1.1 Mb interstitial interval, with preserva-
tion of the terminal 1.77 Mb region in one subject, and a
0.84 Mb interstitial interval, with preservation of the termi-
nal 1.07 Mb region in another. Of note, WHSCR-2,
LETM1 included, was haploinsufficient in both subjects.
Clinically, we found that some features were consistent
with WHS, with particular respect to growth delay in
subject 2 and several facial dysmorphisms in both, but the
whole clinical phenotype was not. More importantly, they
never had clinically evident seizures. It was previously
shown that onset of seizures (or EEG anomalies) in WHS
occur within the first 3 years of life, with a peak incidence
at around 6–12 months of age.1,23 Thus we would not
expect an age effect as a likely explanation for the absence
of seizures in our patients 1 and 2, who were 9 and 4 years
of age at last examination, respectively.
The remaining deletion, affecting the terminal 0.564 Mb
segment on 4p, was detected in two siblings with normal
growth and unremarkable facial appearance, who were
referred because of learning disabilities and seizures.
WHSCR-2, LETM1 included, was fully preserved in both.
The same deletion was detected in the father and in the
paternal grandmother. The father had febrile seizures and
very mild learning difficulties as a child, but he is currently
healthy and a skilled worker. The maternal grandmother
had a single prolonged generalized tonic–clonic seizure epi-
sode with fever at age 2 years, and she had borderline ID.
Although on clinical examination they both presented with
large eyes, arched eyebrows, and high nasal bridge, it is
worth noting that the father was enrolled in genetic testing
with the only purpose to assess inheritance of the chromo-
some rearrangement detected in his children, and the mater-
nal grandmother with the purpose to look for cosegregation
of the seizure disorder and the 4p deletion in the family.
Considering that subjects 3 and 4 in this family shared com-
mon features including generalized epilepsy with febrile
seizures plus, they were first analyzed for the presence of
SCN1Amutations, with normal results. Because impairment
of gene transcription can be caused not only by gene
deletion but also by positional effects, we tested this hypoth-
esis in two subjects (subject 4 and her father), who had
seizures and LETM1 preserved, but LETM1 mRNA levels
were normal. We also investigated whether a loss-of-func-
tion heterozygous mutation on LETM1 segregates in
subjects 3 and 4 and in their affected relatives, but direct
gene sequencing yielded normal results in all. Although a
common genetic cause for seizures, other than the 4p
deletion, can still be hypothesized in this family, a patho-
genic link between the genomic defect and the seizure
phenotype is likely.
We compared our data with those of several literature
reports dealing with either terminal 4p deletions preserving
LETM1, and with interstitial 4p deletions encompassing
LETM1. Looking at our patients and at literature patients as
well, we noted that six of eight subjects with terminal 4p
deletions preserving LETM1 had seizures, whereas seven of
seven with interstitial deletions including LETM1, but pre-
serving a relatively large terminal 4p segment did not
(Fig. 1). It was previously shown that seizures (or EEG
anomalies) occur in about 95% of patients with a diagno-
sis,1,23 leading us to consider that incomplete penetrance
cannot explain absence of seizures in these subjects. Of
importance, the present genotype–phenotype correlation
analysis suggests that haploinsufficiency of LETM1 alone
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may not be sufficient in causing seizures. We found that loss
of the terminal 1.5 Mb region with breakpoint at about
300 kb from the LETM1 locus, preserving LETM1, is criti-
cal for the seizure disorder (Fig. 1 and Table 1). Monosomy
of the terminal 0.4 Mb region on 4p was suggested to be a
normal population variant.15,16 Although no compelling
evidence exists about this assumption, we can tentatively
infer that additional genes for seizures reside in an about
1.1 Mb interval, between 0.4 and 1.5 Mb from the 4p telo-
mere. A comorbidity model for the WHS-associated seizure
disorder can be inferred, implying haploinsufficiency of
LETM1 and of other genes as well.
A total of 23 known annotated genes reside within this
newly characterized interval. Some of them, in particular
CTBP117 and PIGG,18 have already been proposed as can-
didate genes for seizures. We hypothesize that CPLX1,
encoding complexin 1, may be a good additional candi-
date gene for epilepsy in WHS. Complexin 1 is a member
of complexin/synaphin gene family; it is largely expressed
in the mouse brain and primarily in the inhibitory neurons
of the cerebellar cortex, the deep cerebellar nuclei, and
the thalamus.19 Complexins are presynaptic regulatory
proteins that bind reversibly to the soluble NFS attach-
ment protein receptor complex, playing an important role
in the modulation of neurotransmitters release.20 Dysregu-
lation of complexin expression was demonstrated to occur
in neurodegenerative diseases and neuropsychiatric disor-
ders, such as schizophrenia and depressive illness.
Furthermore, Cplx1/ mice display marked deficit in
social behaviors, motor impairment, and brain morpho-
logic changes.21,22 Because Cplx1/ mice do not present
seizures, a comorbidity model with haploinsufficiency of
several genes could be considered for CPLX1 as well.
Further considerations are in order. From a nosologic
point of view, the WHS critical region was tentatively
assigned to a 300–600 Kb region, which was referred to as
WHSCR-2.4 However, we are rather inclined to map the
whole WHS core phenotype within a much larger segment,
ranging from 1.9 to 0.4 Mb from the 4p telomere. Notably,
one subject with a full WHS phenotype, including seizures,
was recently reported to carry an interstitial 4p16.3 deletion
overlapping the same 1.5 Mb interval.24 On the other hand,
it is worth noting that a WHS clinical diagnosis was not
hypothesized by different clinicians with expertise in this
field in subjects 1 and 2, who both had WHRCS-2 deleted
and the terminal 1.77 and 1.07 Mb segment on 4p pre-
served, respectively.
Additional observations can be helpful in supporting the
present genotype–phenotype correlations.
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